1. C-reactive protein: A promising biomarker for poor prognosis in COVID-19 infection
- Author
-
Archana Padhi, Bikash R. Sahu, Raj Kishor Kampa, and Aditya K. Panda
- Subjects
0301 basic medicine ,medicine.medical_specialty ,Funnel plot ,Coronavirus disease 2019 (COVID-19) ,Clinical Biochemistry ,Pneumonia, Viral ,Disease ,Biochemistry ,Article ,Cohort Studies ,03 medical and health sciences ,Betacoronavirus ,0302 clinical medicine ,Non-survivors ,Internal medicine ,medicine ,Humans ,Survivors ,Pandemics ,Biochemistry, medical ,biology ,business.industry ,SARS-CoV-2 ,Biochemistry (medical) ,C-reactive protein ,COVID-19 ,General Medicine ,Publication bias ,Prognosis ,Meta-analysis ,030104 developmental biology ,C-Reactive Protein ,030220 oncology & carcinogenesis ,biology.protein ,Biomarker (medicine) ,business ,CRP ,Coronavirus Infections ,Biomarkers ,Cohort study - Abstract
Highlights • CRP level is elevated in COVID-19 patients. • The present meta-analysis revealed significant association of CRP with poor prognosis of COVID-19 infection. • Role of CRP in COVID-19 infection remained contradictory., Background The novel coronavirus disease 2019 (COVID-19) first broke out in Wuhan, China, spread over 227 countries and caused approximately 0.3 million death worldwide. Several biomolecules have been explored for possible biomarkers for prognosis outcome. Although increased C reactive protein (CRP) is associated with death due to COVID-19 infections, results from different populations remain inconsistent. For a conclusive result, the present meta-analysis was performed. Methods We conducted a literature search in PubMed and Scopus database for the association of CRP concentration with COVID-19 disease outcomes. A total of 16 eligible studies were enrolled in the present analysis comprising of 1896 survivors and 849 non-survivors cases. Concentrations of CRP were compared and analyzed by a meta-analysis. Results Egger’s regression analysis (intercept = 0.04, P = 0.98, 95%CI = −5.48 to 5.58) and funnel plot revealed an absence of publication bias in the included studies. Due to the presence of significant heterogeneity across the studies (Q = 252.03, Pheterogeneity = 0.000, I2 = 93.65) random model was used for the analysis of the present study. The results of the meta-analysis demonstrated a significant role of CRP in COVID-19 infection outcome (Standard difference in means = 1.371, P = 0.000). Conclusions Concentrations of CRP remained high in patients who died of COVID-19 infection and could be a promising biomarker for assessing disease lethality.
- Published
- 2020